Gut microbiome

Gut bacteria can influence brain health, according to a study of mice genetically predisposed to develop Alzheimer’s-like brain damage. The findings suggest a new approach to treating Alzheimer’s and other neurodegenerative diseases.  Context   Researchers at Washington University School of Medicine in St Louis showed that the tens of trillions of microbes that normally live in […]

This is the latest DDW Sitting Down With sponsored podcast, which features Dr John Couse, Vice President of Scientific Services at Taconic Biosciences, who discusses how the microbiome is transforming drug discovery and what this means for pharmaceutical and biotech companies. Couse offers detailed insight into the microbiome and outlines its role in shaping preclinical research. Find The Drug […]

The latest DDW Sitting Down With sponsored podcast is now available. It features Dr John Couse, Vice President of Scientific Services at Taconic Biosciences, who discusses how the microbiome is transforming drug discovery and what this means for pharmaceutical and biotech companies. Couse offers detailed insight into the microbiome and outlines its role in shaping preclinical research. Find […]

An Oxford University study has provided the first evidence that antibiotic resistant bacteria can travel from the gut to the lung, increasing the risk of deadly infections.  The findings coincide with World Antimicrobial Awareness Week and shed light on how antimicrobial resistance (AMR) arises and persists.   The study, which has been published in Nature Communications […]

Microbiome research company Clinical Microbiomics has acquired MS-Omics, a leading provider based in Denmark.   With this acquisition, Clinical Microbiomics hopes to further advance its systems biology platform and help researchers worldwide understand the microbiome and how to impact health and disease.    Anders Grøn, CEO at Clinical Microbiomics, commented: “There is an unmet need in the […]

Danish microbiome research company Clinical Microbiomics has received a €10 million investment from ‘Health for Life Capital II’, managed by Seventure Partners. Microbiome venture capitalists Seventure Partners have backed growth companies in the microbiome field with funding through ‘Health for Life I’ and ‘Health for Life II’ since 2013. Microbiome science is considered to be […]

A new clinical trial, led by the University of Glasgow and NHS Greater Glasgow and Clyde (NHSGGC), hopes to improve treatment options for patients with Crohn’s disease.   The BIOPIC (BIOlogics and Partial enteral nutrition In adults with active ileocolonic Crohn’s disease) study, which is in collaboration with hospitals around Scotland, will evaluate the use […]

UMC Utrecht and its partners have received a research grant to unravel how the intestinal microbiota can be exploited to boost cancer immunotherapy and limit therapy side-effects.  Close to €800,000 was awarded by Health~Holland to a public-private partnership between UMC Utrecht, Artizan Biosciences, Inc. (USA) and MicroViable Therapeutics (Spain).   The project will be headed by […]

Scottish scientists are teaming up with researchers from Zambia to find new ways to diagnose and treat a condition which affects millions in Sub-Saharan Africa.   Ms Kanekwa Zyambo, from the University of Zambia, is spending two weeks at the Scottish Universities Environmental Research Centre in East Kilbride to master new technology to help understand environmental […]

From immunity to metabolism to mental health, it seems like the gut microbiome has been linked to every aspect of human health and disease. But with hundreds of bacterial species populating our gastrointestinal tract, it’s a daunting task to pinpoint which molecules made by which bacteria affect which biological processes—and how they do so. “Microbiome […]